Display options
Cite
Cappabianca P, Alfieri A, Colao A, et al. Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg. 1999;9(2):109-17doi: 10.1055/s-2008-1058157.
Cappabianca, P., Alfieri, A., Colao, A., Ferone, D., Lombardi, G., & de Divitiis, E. (1999). Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull base surgery, 9(2), 109-17. https://doi.org/10.1055/s-2008-1058157
Cappabianca, P, et al. "Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions." Skull base surgery vol. 9,2 (1999): 109-17. doi: https://doi.org/10.1055/s-2008-1058157
Cappabianca P, Alfieri A, Colao A, Ferone D, Lombardi G, de Divitiis E. Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg. 1999;9(2):109-17. doi: 10.1055/s-2008-1058157. PMID: 17171126; PMCID: PMC1656809.
Copy Download .nbib Format: NLM
Share it on

Skull Base Surg. 1999;9(2):109-17. doi: 10.1055/s-2008-1058157.

Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions.

Skull base surgery

P Cappabianca, A Alfieri, A Colao, D Ferone, G Lombardi, E de Divitiis

PMID: 17171126 PMCID: PMC1656809 DOI: 10.1055/s-2008-1058157

Abstract

The outcome of endoscopic endonasal transsphenoidal surgery in 10 patients with pituitary adenomas was compared with that of traditional transnasal transsphenoidal approach (TTA) in 20 subjects. Among the 10 individuals subjected to "pure endoscopy," 2 had a microadenoma, 1 an intrasellar macroadenoma, 4 had a macroadenoma with suprasellar expansion, 2 had a macroadenoma with supra-parasellar expansion, and 1 a residual tumor; 5 had acromegaly and 5 had a nonfunctioning adenoma (NFA). Among the patients subjected to TTA, 4 had a microadenoma, 2 had an intrasellar macroadenoma, 6 had a macroadenoma with suprasellar expansion, 4 had a macroadenoma with supra-parasellar expansion, and 4 had a residual tumor; 9 patients had acromegaly, 1 hyperprolactinemia, 1 Cushing's disease, and 9 a NFA. At the macroscopic evaluation, tumor removal was total (100%) after endoscopy in 9 patients and after TTA in 14 patients. Six months after surgery, magnetic resonance imaging (MRI) confirmed the total tumor removal in 21 of 23 patients (91.3%). Circulating growth hormone (GH) and insulin-like growth factor-I (IGF-I) significantly decreased 6 months after surgery in all 14 acromegalic patients: normalization of plasma IGF-I levels was obtained in 4 of 5 patients after the endoscopic procedure and in 4 of 9 patients after TTA. Before surgery, pituitary hormone deficiency was present in 14 out of 30 patients: pituitary function improved in 4 patients, remaining unchanged in the other 10 patients. Visual field defects were present before surgery in 4 patients, and improved in all. Early surgical results in the group of 10 patients who underwent endoscopic pituitary tumor removal were at least equivalent to those of standard TTA, with excellent postoperative course. Postsurgical hospital stay was significantly shorter (3.1 +/- 0.4 vs. 6.2 +/- 0.3 days, p < 0.001) after endoscopy as compared to TTA.

References

  1. Endocrinol Metab Clin North Am. 1992 Sep;21(3):669-92 - PubMed
  2. Surg Neurol. 1992 Mar;37(3):189-96 - PubMed
  3. BMJ. 1992 May 23;304(6838):1343-6 - PubMed
  4. J Clin Endocrinol Metab. 1995 Dec;80(12):3395-402 - PubMed
  5. J Endocrinol Invest. 1996 Mar;19(3):196-8 - PubMed
  6. Neurosurgery. 1997 Feb;40(2):225-36; discussion 236-7 - PubMed
  7. Surg Neurol. 1997 Mar;47(3):213-22; discussion 222-3 - PubMed
  8. J Clin Endocrinol Metab. 1997 Apr;82(4):996-1000 - PubMed
  9. J Neurosurg. 1997 Jul;87(1):44-51 - PubMed
  10. J Clin Endocrinol Metab. 1997 Sep;82(9):2777-81 - PubMed
  11. J Clin Endocrinol Metab. 1997 Oct;82(10):3185-6 - PubMed
  12. J Clin Endocrinol Metab. 1997 Oct;82(10):3308-14 - PubMed
  13. Adv Neurol. 1976;15:261-73 - PubMed
  14. J Endocrinol Invest. 1998 May;21(5):284-90 - PubMed
  15. Minim Invasive Neurosurg. 1998 Jun;41(2):66-73 - PubMed
  16. Clin Neurosurg. 1976;23:401-16 - PubMed
  17. Surg Neurol. 1993 Jan;39(1):18-24 - PubMed
  18. J Neurosurg. 1993 Feb;78(2):205-15 - PubMed
  19. BMJ. 1993 Dec 11;307(6918):1505-6 - PubMed
  20. J Clin Endocrinol Metab. 1994 Aug;79(2):348-54 - PubMed
  21. J Endocrinol Invest. 1994 Oct;17(9):703-7 - PubMed
  22. Neurosurgery. 1995 Apr;36(4):668-75; discussion 675-6 - PubMed
  23. Fertil Steril. 1981 Jun;35(6):620-5 - PubMed
  24. J Neurosurg. 1980 May;52(5):661-6 - PubMed
  25. Mayo Clin Proc. 1983 Feb;58(2):108-21 - PubMed
  26. Int J Radiat Oncol Biol Phys. 1981 Feb;7(2):243-52 - PubMed
  27. Clin Neurosurg. 1969;16:185-217 - PubMed
  28. J Neurosurg. 1979 Apr;50(4):454-61 - PubMed
  29. Surg Neurol. 1986 Oct;26(4):338-44 - PubMed
  30. J Neurosurg. 1986 Jul;65(1):22-7 - PubMed
  31. J Neurosurg. 1986 May;64(5):713-9 - PubMed
  32. J Neurosurg. 1988 Jun;68(6):854-67 - PubMed
  33. Am J Med. 1986 Sep;81(3):457-62 - PubMed
  34. Ann Intern Med. 1988 Sep 15;109(6):487-93 - PubMed
  35. J Neurosurg. 1990 Mar;72(3):363-9 - PubMed
  36. J Neurosurg. 1990 Oct;73(4):502-12 - PubMed
  37. Eur Arch Otorhinolaryngol. 1990;247(2):63-76 - PubMed
  38. Pathol Res Pract. 1991 Jun;187(5):608-12 - PubMed

Publication Types